Ying Xue Selected Research

Phytohemagglutinins

1/2022	Machine learning based on routine laboratory indicators promoting the discrimination between active tuberculosis and latent tuberculosis infection.
4/2021	Combination of prealbumin and tuberculosis-specific antigen/phytohemagglutinin ratio for discriminating active tuberculosis from latent tuberculosis infection.
1/2021	Diagnostic Model for Discrimination Between Tuberculous Meningitis and Bacterial Meningitis.
1/2021	Combination of HLA-DR on Mycobacterium tuberculosis-Specific Cells and Tuberculosis Antigen/Phytohemagglutinin Ratio for Discriminating Active Tuberculosis From Latent Tuberculosis Infection.
8/2020	A combination of iron metabolism indexes and tuberculosis-specific antigen/phytohemagglutinin ratio for distinguishing active tuberculosis from latent tuberculosis infection.
1/2020	Combination of mean spot sizes of ESAT-6 spot-forming cells and modified tuberculosis-specific antigen/phytohemagglutinin ratio of T-SPOT.TB assay in distinguishing between active tuberculosis and latent tuberculosis infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying Xue Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 10/2007
18	Infections 12/2022 - 01/2003
18	Tuberculosis (Tuberculoses) 01/2022 - 01/2003
10	Inflammation (Inflammations) 01/2022 - 01/2012
5	COVID-19 11/2021 - 01/2020
5	Acute Coronary Syndrome 05/2021 - 06/2017
4	Latent Tuberculosis 04/2021 - 01/2020
4	Aneuploidy (Aneuploid) 12/2019 - 07/2018
3	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 09/2014
3	Acute Lung Injury 03/2022 - 01/2016
3	Stomach Neoplasms (Stomach Cancer) 03/2022 - 08/2020
3	Hemorrhage 01/2021 - 02/2018
3	Atrial Fibrillation 01/2021 - 07/2017
3	Diarrhea 10/2020 - 09/2013
3	Stroke (Strokes) 10/2020 - 12/2013
3	Neoplasm Metastasis (Metastasis) 10/2019 - 06/2017
3	Type 2 Diabetes Mellitus (MODY) 08/2018 - 01/2016
3	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 03/2010
3	Obesity 05/2016 - 09/2009
3	Vitamin D Deficiency 01/2016 - 01/2015
3	Necrosis 09/2012 - 01/2012
2	Bites and Stings (Sting) 01/2022 - 12/2021
2	Trichinellosis 01/2022 - 12/2021
2	Brain Ischemia (Cerebral Ischemia) 01/2022 - 11/2020
2	Hypertension (High Blood Pressure) 11/2021 - 01/2016
2	Fibrosis (Cirrhosis) 09/2021 - 10/2019
2	Thrombosis (Thrombus) 01/2021 - 01/2021
2	Overweight 01/2021 - 05/2016
2	Cognitive Dysfunction 11/2020 - 01/2018
2	Pain (Aches) 10/2020 - 01/2016
2	Substance-Related Disorders (Drug Abuse) 10/2020 - 01/2020
2	Nausea 10/2020 - 09/2015
2	Myocardial Infarction 10/2020 - 01/2018
2	Nasopharyngeal Carcinoma 01/2020 - 09/2012
2	Atherosclerosis 01/2020 - 03/2016
2	Carcinogenesis 04/2019 - 01/2019
2	Adenocarcinoma 04/2019 - 01/2019
2	Osteoporosis 01/2019 - 09/2014
2	Trisomy 13 Syndrome 01/2019 - 07/2018
2	Hypoxia (Hypoxemia) 01/2019 - 12/2014
2	Fatty Liver 01/2018 - 12/2013

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2003
11	VaccinesIBA 12/2022 - 02/2004
8	AntigensIBA 01/2022 - 09/2018
6	PhytohemagglutininsIBA 01/2022 - 01/2020
6	Pharmaceutical PreparationsIBA 01/2021 - 03/2010
5	Messenger RNA (mRNA)IBA 01/2022 - 09/2014
5	CytokinesIBA 09/2021 - 09/2012
5	TicagrelorIBA 05/2021 - 06/2017
5	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 09/2009
5	Biological ProductsIBA 04/2019 - 02/2010
4	Interleukin-10 (Interleukin 10)IBA 07/2022 - 01/2012
4	Angiotensin-Converting Enzyme 2IBA 03/2022 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2017
4	Vitamin D FDA LinkGeneric 01/2016 - 04/2013
3	Monoclonal AntibodiesIBA 12/2022 - 03/2015
3	LipopolysaccharidesIBA 03/2022 - 01/2016
3	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2016
3	AlbuminsIBA 01/2022 - 11/2016
3	Adenosine (Adenocard)FDA LinkGeneric 04/2021 - 06/2017
3	IronIBA 08/2020 - 06/2005
3	CalciumIBA 01/2017 - 11/2014
3	Interleukin-6 (Interleukin 6)IBA 09/2016 - 12/2014
3	InterleukinsIBA 09/2016 - 01/2012
2	Interleukin-4 (Interleukin 4)IBA 07/2022 - 09/2021
2	Interleukin-12 (IL 12)IBA 07/2022 - 06/2008
2	Interferon Type IIBA 01/2022 - 12/2021
2	Sirtuin 1IBA 01/2022 - 12/2013
2	DNA VaccinesIBA 01/2022 - 01/2003
2	Docosahexaenoic AcidsIBA 01/2022 - 06/2018
2	InflammasomesIBA 12/2021 - 01/2021
2	Antihypertensive Agents (Antihypertensives)IBA 11/2021 - 01/2018
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 05/2021 - 01/2018
2	Prealbumin (Transthyretin)IBA 04/2021 - 01/2020
2	Cilostazol (Pletal)FDA LinkGeneric 04/2021 - 02/2018
2	Uric Acid (Urate)IBA 01/2021 - 09/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2008
2	Dabigatran FDA Link 01/2021 - 01/2021
2	RivaroxabanIBA 01/2021 - 01/2021
2	Amino Acids FDA Link 01/2021 - 09/2017
2	Opioid Analgesics (Opioids)IBA 10/2020 - 02/2013
2	Clopidogrel (Plavix)FDA Link 10/2020 - 06/2017
2	Interleukin-8 (Interleukin 8)IBA 10/2020 - 10/2019
2	OsteocalcinIBA 03/2020 - 01/2012
2	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2020 - 01/2019
2	N-(4-isothiocyanatophenethyl)spiperoneIBA 01/2020 - 12/2019
2	IntegrinsIBA 01/2020 - 01/2012
2	CateninsIBA 04/2019 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2012
2	dichlorobis(azomycin)platinum IIIBA 01/2019 - 07/2018
2	Subunit VaccinesIBA 12/2018 - 02/2004
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2018 - 04/2016
2	AcidsIBA 01/2018 - 05/2007

Therapy/Procedure

14	Therapeutics 05/2022 - 10/2009
3	Radiotherapy 10/2014 - 09/2012
2	Gastrectomy 03/2022 - 08/2020
2	Precision Medicine 12/2021 - 04/2021
2	Lasers (Laser) 12/2021 - 09/2013
2	Pain Management 10/2020 - 10/2007
2	Length of Stay 08/2020 - 12/2013